Abstract
Venous thromboembolism (VTE) continues to be a common medical problem requiring the need for rapid treatment with anticoagulant therapy. Until the recent availability of the direct oral anticoagulants for treatment of VTE, the option for oral anticoagulation was limited to warfarin therapy. The addition of these new medications has been welcomed, but has led to added complexities in deciding the most appropriate agent for each patient based on individual risk factors. Furthermore, there are several circumstances where optimal duration of therapy is not well established. This article will focus on the diagnosis of VTE, the choice of anticoagulant and treatment duration.
Original language | English |
---|---|
Pages (from-to) | 1175-1184 |
Number of pages | 10 |
Journal | Internal Medicine Journal |
Volume | 48 |
Issue number | 10 |
DOIs | |
Publication status | Published - Oct 2018 |
Keywords
- anticoagulation
- deep vein thrombosis
- direct oral anticoagulants
- pulmonary embolism
- venous thromboembolism